Evidence for the role of metabotropic glutamate (mGlu)2 not mGlu3 receptors in the preclinical antipsychotic pharmacology of the mGlu2/3 receptor agonist (-)-(1R,4S,5S,6S)-4-amino-2-sulfonylbicyclo[3.1.0]hexane-4,6-dicarboxylic acid (LY404039). (Q46634848)
Jump to navigation
Jump to search
scientific article published on 18 April 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Evidence for the role of metabotropic glutamate (mGlu)2 not mGlu3 receptors in the preclinical antipsychotic pharmacology of the mGlu2/3 receptor agonist (-)-(1R,4S,5S,6S)-4-amino-2-sulfonylbicyclo[3.1.0]hexane-4,6-dicarboxylic acid (LY404039). |
scientific article published on 18 April 2008 |
Statements
1 reference
Evidence for the role of metabotropic glutamate (mGlu)2 not mGlu3 receptors in the preclinical antipsychotic pharmacology of the mGlu2/3 receptor agonist (-)-(1R,4S,5S,6S)-4-amino-2-sulfonylbicyclo[3.1.0]hexane-4,6-dicarboxylic acid (LY404039). (English)
1 reference
Matthew J Fell
1 reference
Kjell A Svensson
1 reference
Bryan G Johnson
1 reference
Darryle D Schoepp
1 reference
18 April 2008
1 reference
326
1 reference
1
1 reference
209-217
1 reference
Identifiers
1 reference
1 reference